Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

VHAG in Treating R/R T-ALL/LBL

NCT06742463

Conditions: Acute T Lymphpblastic Leukemia/Lymphoma, Disease Attributes, Hematologic Diseases, +14 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL

NCT06742515

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003 Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Real-World Study of DLBCL With Different Genetic Subtypes

NCT06026488

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +9 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Intratumoral CAN2109 in Subjects With Solid Tumors

NCT06332430

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Sun Yat-Sen University Sun Yat-Sen Memorial Hospital Guangzhou, Guangdong, China

View Trial Details

Recruiting

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

NCT06739265

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

NCT06561854

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Service d'hématologie clinique et thérapie cellulaire, Saint-Antoine Hospital Paris, France

View Trial Details

Recruiting

Ovarian Hyperstimulation Syndrome Prevention

NCT06739759

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Aljazeerah hospital Giza, Egypt

Algazeerah Giza, Egypt

View Trial Details

Recruiting

Solving Riddles Through Sequencing

NCT05046444

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Malignancy, +20 more
Locations: MLL Munich Leukemia Laboratory Munich, Germany

View Trial Details

Recruiting

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

NCT06209606

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Berenson Cancer Center West Hollywood, California, United States

View Trial Details

Recruiting

Better Leukemia Diagnostics Through AI (BELUGA)

NCT04466059

Conditions: Blood Cancer, Hematologic Diseases, Hematologic Malignancy, +16 more
Locations: MLL Munich Leukemia Laboratory Munich, Bavaria, Germany

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions